Trial Profile
Expanded Access Study for Renal Transplant Patients With Envarsus XR: Envarsus 3007
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 08 Jan 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Expanded access; Therapeutic Use
- Sponsors Veloxis Pharmaceuticals
- 29 May 2015 Status changed from not stated to unconfirmed.
- 13 Apr 2015 New trial record